Paracetamol intravenous - Bristol-Myers Squibb/Mallinckrodt
Alternative Names: Acelio; acetaminophen IV; Acetavance; IV APAP; Ofirmev; Perfalgan; TRM-1106Latest Information Update: 31 Dec 2021
At a glance
- Originator Pharmatop
- Developer Bristol-Myers Squibb; Mallinckrodt plc; Terumo
- Class Acetanilides; Aminophenols; Antipyretics; Non-opioid analgesics; Small molecules
- Mechanism of Action Prostaglandin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Fever; Pain
Most Recent Events
- 02 Jun 2017 No recent reports on development identified - Registered for Fever and Pain in Canada (IV)
- 18 Nov 2016 Mallinckrodt Pharmaceuticals completes a Pharmacokinetics trial in United Kingdom
- 08 Nov 2016 The US FDA approved a Prior Approval Supplement for acetaminophen injection